Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Molecular therapy for Metabolic disorders: SNAI increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 26/October/2014, 13.12, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Undisclosed information: An insight into how SNAI increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia.
Significance: This study suggests, for the first time, that SNAI, by increasing the expression of IL-22, it may increase insulin sensitivity, restore gut immunity and decrease endotoxaemia. Together, this study suggests that pharmacological formulations encompassing “SNAI activators” may be used to treat metabolic disorders, including T2DM and cardiac diseases.
